Evaluation of cardiac output variations with the peripheral pulse pressure to mean arterial pressure ratio.
Adult
Aged
Anesthesia
Arterial Pressure
Blood Pressure
Cardiac Output
Ephedrine
/ therapeutic use
Female
Heart Rate
Hemodynamics
Humans
Male
Middle Aged
Monitoring, Physiologic
/ instrumentation
Neurosurgical Procedures
Norepinephrine
/ therapeutic use
Operating Rooms
Phenylephrine
/ therapeutic use
Stroke Volume
Systole
Ultrasonography, Doppler
Vasoconstrictor Agents
/ pharmacology
Cardiac output
Mean arterial pressure
PP/MAP
Pressure pulse analysis
Pulse pressure
Vasopressor challenges
Journal
Journal of clinical monitoring and computing
ISSN: 1573-2614
Titre abrégé: J Clin Monit Comput
Pays: Netherlands
ID NLM: 9806357
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
20
06
2018
accepted:
08
10
2018
pubmed:
27
10
2018
medline:
9
4
2020
entrez:
27
10
2018
Statut:
ppublish
Résumé
Cardiac output (CO) optimisation during surgery reduces post-operative morbidity. Various methods based on pulse pressure analysis have been developed to overcome difficulties to measure accurate CO variations in standard anaesthetic settings. Several of these methods include, among other parameters, the ratio of pulse pressure to mean arterial pressure (PP/MAP). The aim of this study was to evaluate whether the ratio of radial pulse pressure to mean arterial pressure (ΔPPrad/MAP) could track CO variations (ΔCO) induced by various therapeutic interventions such as fluid infusions and vasopressors boluses [phenylephrine (PE), norepinephrine (NA) or ephedrine (EP)] in the operating room. Trans-oesophageal Doppler signal and pressure waveforms were recorded in patients undergoing neurosurgery. CO and PPrad/MAP were recorded before and after fluid challenges, PE, NA and EP bolus infusions as medically required during their anaesthesia. One hundred and three patients (mean age: 52 ± 12 years old, 38 men) have been included with a total of 636 sets of measurement. During fluids challenges (n = 188), a positive correlation was found between ΔPPrad/MAP and ΔCO (r = 0.22, p = 0.003). After PE (n = 256) and NA (n = 121) boluses, ΔPPrad/MAP positively tracked ΔCO (r = 0.53 and 0.41 respectively, p < 0.001). By contrast, there was no relation between ΔPPrad/MAP and ΔCO after EP boluses (r = 0.10, p = 0.39). ΔPPrad/MAP tracked ΔCO variations during PE and NA vasopressor challenges. However, after positive fluid challenge or EP boluses, ΔPPrad/MAP was not as performant to track ΔCO which could make the use of this ratio difficult in current clinical practice.
Identifiants
pubmed: 30361823
doi: 10.1007/s10877-018-0210-8
pii: 10.1007/s10877-018-0210-8
doi:
Substances chimiques
Vasoconstrictor Agents
0
Phenylephrine
1WS297W6MV
Ephedrine
GN83C131XS
Norepinephrine
X4W3ENH1CV
Types de publication
Comparative Study
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
581-587Références
Br J Anaesth. 2011 Jun;106(6):776-84
pubmed: 21441548
Circ Res. 1966 Mar;18(3):278-92
pubmed: 5904318
Anesth Analg. 2018 Jun;126(6):1930-1933
pubmed: 29077613
Crit Care. 2013 Jun 20;17(3):R113
pubmed: 23787086
Anesth Analg. 2011 Jun;112(6):1392-402
pubmed: 20966436
Curr Opin Cardiol. 2005 Jul;20(4):275-81
pubmed: 15956823
Anesth Analg. 2007 Jul;105(1):107-13
pubmed: 17578965
Br J Anaesth. 2015 Jun;114(6):893-900
pubmed: 25735709
Crit Care Med. 2007 Feb;35(2):477-82
pubmed: 17204996
Crit Care. 2011;15(1):R22
pubmed: 21241481
Ann Intensive Care. 2016 Dec;6(1):111
pubmed: 27858374
Anesth Analg. 2010 Nov;111(5):1180-92
pubmed: 20736431
JAMA. 2014 Jun 4;311(21):2181-90
pubmed: 24842135
Am J Physiol. 1991 Jul;261(1 Pt 2):R126-33
pubmed: 1858938
J Hypertens. 2012 Aug;30(8):1540-51
pubmed: 22635139
Anesth Analg. 2011 Oct;113(4):751-7
pubmed: 21821516
Crit Care. 2009;13(1):201
pubmed: 19183431